Biological properties of human c-Ha-ras1 genes mutated at codon 12 - PubMed (original) (raw)
. 1984 Nov;312(5989):71-5.
doi: 10.1038/312071a0.
- PMID: 6092966
- DOI: 10.1038/312071a0
Biological properties of human c-Ha-ras1 genes mutated at codon 12
P H Seeburg et al. Nature. 1984 Nov.
Abstract
Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems to be involved in the development of naturally occurring tumours. These activated genes, usually assayed by their ability to induce the malignant transformation of NIH 3T3 cells, are frequently related to the ras oncogene of Harvey (Ha-ras) or Kirsten (Ki-ras) murine sarcoma viruses, or a third member of this family (N-ras). Activation involves point mutation which often affect codon 12 (refs 16-26) of the encoded 21,000-molecular weight polypeptide (p21). To provide insight into structural requirements involved in p21 activation, we have now constructed 20 mutant c-Ha-ras1 genes by in vitro mutagenesis, each encoding a different amino acid at codon 12. Analysis of rat fibroblasts transfected with these altered genes demonstrates that all amino acids except glycine (which is encoded by normal cellular ras genes) and proline at position 12 activate p21, suggesting a requirement for an alpha-helical structure in this region of the polypeptide. The morphological phenotype of cells transformed by the activated genes can, however, depend on the particular amino acid at this position.
Similar articles
- Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.
Fujita J, Yoshida O, Yuasa Y, Rhim JS, Hatanaka M, Aaronson SA. Fujita J, et al. Nature. 1984 May 31-Jun 6;309(5967):464-6. doi: 10.1038/309464a0. Nature. 1984. PMID: 6328318 - Transformation of NIH3T3 cells with synthetic c-Ha-ras genes.
Kamiya H, Miura K, Ohtomo N, Koda T, Kakinuma M, Nishimura S, Ohtsuka E. Kamiya H, et al. Jpn J Cancer Res. 1989 Mar;80(3):200-3. doi: 10.1111/j.1349-7006.1989.tb02291.x. Jpn J Cancer Res. 1989. PMID: 2542206 Free PMC article. - Activation of a human c-K-ras oncogene.
Yamamoto F, Perucho M. Yamamoto F, et al. Nucleic Acids Res. 1984 Dec 11;12(23):8873-85. doi: 10.1093/nar/12.23.8873. Nucleic Acids Res. 1984. PMID: 6096811 Free PMC article. - Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH, Morgan PL, Lee EJ, Pirollo KF, White EA, Patrick DH, Tsichlis PN. Chang EH, et al. J Exp Pathol. 1985 Fall;2(3):177-89. J Exp Pathol. 1985. PMID: 3842394 - The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS. Cooper CS. Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333. Environ Health Perspect. 1991. PMID: 1685444 Free PMC article. Review.
Cited by
- Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.
Kwon JJ, Dilly J, Liu S, Kim E, Bian Y, Dharmaiah S, Tran TH, Kapner KS, Ly SH, Yang X, Rabara D, Waybright TJ, Giacomelli AO, Hong AL, Misek S, Wang B, Ravi A, Doench JG, Beroukhim R, Lemke CT, Haigis KM, Esposito D, Root DE, Nissley DV, Stephen AG, McCormick F, Simanshu DK, Hahn WC, Aguirre AJ. Kwon JJ, et al. bioRxiv [Preprint]. 2024 Oct 25:2024.10.22.618529. doi: 10.1101/2024.10.22.618529. bioRxiv. 2024. PMID: 39484452 Free PMC article. Preprint. - Predicting prognosis in colorectal cancer patients with curative resection using albumin, lymphocyte count and RAS mutations.
Miyata T, Hayama T, Ozawa T, Nozawa K, Misawa T, Fukagawa T. Miyata T, et al. Sci Rep. 2024 Jun 23;14(1):14428. doi: 10.1038/s41598-024-65457-8. Sci Rep. 2024. PMID: 38910183 Free PMC article. - Progress in Targeting KRAS Directly.
Nissley DV, Stephen AG, Yi M, McCormick F. Nissley DV, et al. Methods Mol Biol. 2024;2797:1-12. doi: 10.1007/978-1-0716-3822-4_1. Methods Mol Biol. 2024. PMID: 38570448 - Neuronal Protection by Ha-RAS-GTPase Signaling through Selective Downregulation of Plasmalemmal Voltage-Dependent Anion Channel-1.
Neumann S, Kuteykin-Teplyakov K, Heumann R. Neumann S, et al. Int J Mol Sci. 2024 Mar 6;25(5):3030. doi: 10.3390/ijms25053030. Int J Mol Sci. 2024. PMID: 38474278 Free PMC article. - RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.
Schaefer A, Hodge RG, Zhang H, Hobbs GA, Dilly J, Huynh MV, Goodwin CM, Zhang F, Diehl JN, Pierobon M, Baldelli E, Javaid S, Guthrie K, Rashid NU, Petricoin EF, Cox AD, Hahn WC, Aguirre AJ, Bass AJ, Der CJ. Schaefer A, et al. Sci Signal. 2023 Dec 19;16(816):eadg5289. doi: 10.1126/scisignal.adg5289. Epub 2023 Dec 19. Sci Signal. 2023. PMID: 38113333 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous